SAUDI ARABIA – Global technology powerhouse Lenovo and Saudi Arabia-based biotech startup Novo Genomics have entered a research agreement to utilize the latest technologies in genomics and multi-omics.
In line with the agreement, Novo Genomics will leverage scientific advances at Lenovo through advanced analytics and data mining to promote health and wellness in the Kingdom of Saudi Arabia.
Novo consists of a high-level team of bioinformatics scientists, consultants, and clinicians empowered to put all the right strategies in place to transform the concept of health, wellness and quality of life.
Lenovo will deploy its GOAST (Genomics Optimisation and Scalability Tool) solution to Saudi Arabia through Novo Genomics, thereby enabling research that is 167x faster than standard environments.
Novo Genomics becomes the first customer of the Lenovo Genomics Optimization and Analysis Tool in Europe, the Middle East, and Africa region.
Lenovo’s GOAST solution is available in two variants, GOAST Base and GOAST Plus which deliver improvements of 18X-45X and 67X-167X respectively.
Moreover, it uses validated software and comes packed with pre-configured genomics analytics solutions.
“Lenovo is a pioneer in accelerating genomics analytics, which is evident by our GOAST tools which not only offer higher degrees of performance and reliability but also keeps it cost-effective,” said Alaa Bawab, General Manager for the Middle East and Africa, for Lenovo Infrastructure Solutions Group.
He pointed out that researchers in fields of life sciences, precision medicine and infectious diseases can the GOAST tools to understand data faster and efficiently decode genomics.
“Our R&D groups have ensured that all the supporting work is already done, which leaves users with optimized settings for high-performing results from the moment they setup,” Bawab added.
The Lenovo GOAST solution will allow researchers to analyze a whole human genome in less than 53 minutes, and whole exomes in about a minute
Researchers will be able to process multiple genomes concurrently, find answers faster, and make breakthroughs sooner than expected.
In his address, Dr. Budoor Almansour, Chief Operating Officer and Co-founder of Novo Genomics, said: “Given the high prevalence of genetic diseases in the region, we are committed to genomics as a vital field to enrich the sector with qualified Saudi expertise.”
Novo Genomics is fully aligned with the Saudi Vision 2030 which advocates for increased capacity for scientific research and innovation.
Lenovo’s GOAST solution will also build the capacity of dedicated research centers and institutions such as the King AbdulAziz City for Science and Technology and King Abdullah International Medical Research Centre.
For all the latest healthcare industry news from Africa and the World, subscribe to our NEWSLETTER, and YouTube Channel, follow us on Twitter and LinkedIn, and like us on Facebook.
